![](https://kayentis.com/wp-content/uploads/2024/05/epro_consortium_logo.jpg)
Kayentis extends its contribution to scientific research in clinical trial endpoint assessment and joins the Critical Path Institute’s ePRO Consortium
Kayentis announces that it has joined the C-Path's ePRO Consortium, a nonprofit organization dedicated to advance the science of clinical trial endpoint assessment, and will contribute to the “eCOA Getting...